PROCESSA PHARMACEUTICALS INC (PCSA) Stock Income Statement
NASDAQ:PCSA - Nasdaq - US74275C3043 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 12.08M | 12.00M | 11.46M | 20.26M | 11.57M | |||
| Research and Development | 7.32M | N/A | 5.80M | 10.71M | 6.09M | |||
| Selling, General, and Administrative Expenses | 4.77M | 4.78M | 5.66M | 8.76M | 4.69M | |||
| Operating Income | -12.08M | -12.00M | -11.46M | -20.26M | -11.57M | |||
| Interest Income/Expense | 130.50K | N/A | 335.50K | 101.20K | 11.60K | |||
| Non Recurring Items | N/A | N/A | 0.00 | -7.27M | -402.80K | |||
| Income Before Taxes | -11.95M | -12.00M | -11.12M | -27.42M | -11.96M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | -530.60K | |||
| Net Income | -11.95M | -12.00M | -11.12M | -27.42M | -11.43M | |||
| EBITDA | N/A | N/A | -11.46M | -19.47M | -10.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.12 | -3.92 | -8.48 | -34.05 | -14.92 | |||
| Non GAAP EPS | -3.08 | -3.89 | N/A | -25.00 | -14.80 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD